Today, Vice President Joe Biden and Victoria Espinel, Intellectual Property Enforcement Coordinator, released the U.S. government’s official IP enforcement strategy. The plan — developed following extensive public consultation — identifies 33 key action items to combat intellectual property infringement, both domestically and internationally.
Download the PDF to read the complete 2010 Joint Strategic Plan on Intellectual Property Enforcement.
The following are highlights from Vice President Joe Biden’s remarks, delivered today at the Eisenhower Executive Office Building:
Whether we’re talking about fake drugs that hurt instead of help the patient or knockoff car tires that fall apart at 65 miles an hour causing injury and death, counterfeits kill — counterfeits kill. There’s a reason why they counterfeit, they don’t know how to do it in the first place.
But to state it very bluntly and obviously, piracy hurts. It hurts our economy to the tune of billions — some argue tens of billions of dollars — in lost private sector profit and government revenue. It hurts our health and safety, the health and safety — that’s why the FDA commissioner is here, in part.
Piracy is theft, clean and simple. It’s nothing but theft.
Filed under: Commentary on news & events, intellectual property, North America Tagged: | counterfeit medicines, intellectual property, United States of America
US releases IP enforcement strategy
Today, Vice President Joe Biden and Victoria Espinel, Intellectual Property Enforcement Coordinator, released the U.S. government’s official IP enforcement strategy. The plan — developed following extensive public consultation — identifies 33 key action items to combat intellectual property infringement, both domestically and internationally.
Download the PDF to read the complete 2010 Joint Strategic Plan on Intellectual Property Enforcement.
The following are highlights from Vice President Joe Biden’s remarks, delivered today at the Eisenhower Executive Office Building:
Share this:
Filed under: Commentary on news & events, intellectual property, North America Tagged: | counterfeit medicines, intellectual property, United States of America